What Plains GP Holders Bought Into

If you only skimmed the headlines about Plains GP selling assets, reshaping its portfolio and reporting a wider loss in 2026, you might not expect shareholders to be smiling. Investors who held Plains GP from the start of the year are up 42.1%, including dividends. If you had been weighing up Plains GP on 1 January, with bulls and bears split on Permian pipelines and decarbonization risk, what exactly in that early record justified taking the plunge?

The useful thing about a Narrative is that the reasoning is checkable: the assumptions sit beside the argument, and together they imply an estimated Fair Value you can disagree with.

If the move has made Plains GP harder to judge, start where the gap is still open and scan 39 high quality undervalued stocks.

The Argument You Would Have Been Weighing Up On Plains GP

The shares cost US$19.14 at the start of the period, and anyone looking at Plains GP had two clear stories to weigh.

On the bullish side, the Fair Value sat at US$26, built on the idea that strong Permian production and tight pipeline capacity would let Plains GP use its integrated network and fee-based contracts to support margin expansion.

The bearish Narrative put Fair Value at US$17.5, warning that decarbonization policies and tighter regulation could restrict Permian pipeline use and leave parts of the network at risk of underutilization.

What The Plains GP Evidence Actually Tested

The defining event for Plains GP was completion of the roughly US$3.76b sale of its Canadian NGL business, with about US$3.3b of cash earmarked mainly for debt repayment. That supported the cautious case that focused on balance sheet strength rather than aggressive expansion. At the same time, revenue rose from US$10,642m to US$17,693m while the business reported a larger loss of US$1,260m and a weaker net margin, so the profitability part of the bullish story stayed unproven. Overall, the evidence cut both ways.

The key assumption you would test at another midstream operator is that higher throughput and portfolio reshaping will translate into better profitability rather than just more volume. You would track the direction of net income and net margin in each report against any promised capital recycling, asset sales or growth projects before accepting that thesis.

What Plains GP's Price Already Assumes After A 42% Run

Plains GP trades at US$25.78, and the selected Narrative’s Fair Value sits below that level. The gap is not about energy transition fears. It focuses on whether crude focused projects and cost savings really turn into steady free cash flow.

A buyer today effectively assumes those crude systems, expansions and efficiencies support ongoing cash generation. The selected Narrative asks how much room that leaves if growth projects, volume trends or cost cuts underperform.

"The main thing that has to go right is that Plains GP Holdings successfully turns its crude oil midstream focus, brownfield expansions, and identified cost efficiencies into durable free cash flow while keeping leverage around its stated 3.25x to 3.75x range. The current valuation implies the share price already reflects continued execution on crude segment growth projects, recurring distribution increases, and high free cash flow generation, which leaves limited room for disappointment."

That disagreement has a full argument behind it. → Uncover the lower Fair Value this Narrative argues for

Another Midstream Question Near Plains GP

If Plains GP has you thinking about pipes and terminals, take one extra step. Shift your attention from barrels handled to what keeps future flows possible.

Large energy users still need reliable transport and storage for both crude and gas. A different operator is building new gas lines, caverns and related projects.

It leans on regulated and contracted assets, with fees tied to usage instead of commodity swings. Storage expansions and fresh routes keep molecules moving when grids and export sites call.

For someone studying Plains GP, that nearby build out prompts a sharper question. What value might sit in midstream capacity still being stitched together?

The case is on the record, with the assumptions it rests on. → See the Narrative that values this company 20% above its price

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com